But a person on semaglutide is experiencing GLP-1 receptor activation at levels that dwarf anything your body naturally produces, because synthetic GLP-1 receptor agonists are designed to be resistant to the DPP-4 enzyme that rapidly degrades natural GLP-1
Healthcare practitioners do not recommend using GLP-1s for PMOS if you are pregnant or trying to conceive
5, 2025 /PRNewswire/ -- Novo Nordisk today announced the filing of 14 new lawsuits to safeguard patients from unsafe and unapproved compounded drugs claiming to contain "semaglutide." The defendants named in these lawsuits employ tactics that deceive patients into believing compounded products have been reviewed and approved by FDA or have equivalent safety or effectiveness as Novo Nordisk's approved semaglutide medicines
Weight loss clearly improves the response to drugs, not to mention a myriad of obesity- and psoriasis-related comorbidities
Keep all medications safely out of reach of children and pets
Patient ratings carry the most weight, followed by the number of verified reviews, provider credentials (including ABOM board certification in obesity medicine), and verification level
